Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Updated 12 August 2021

The National Immunisation Advisory Committee (NIAC) together with the Irish Association of Allergy and Immunology (IAAI) have produced a Frequently Asked Questions (FAQ) document about COVID-19 vaccines for people with pre-existing allergic conditions.

The Frequently Asked Questions (FAQ) document, available to view and download below, has been created as supplemental information to aid vaccinators and other front-line healthcare professionals (GPs, Occupational Health etc.). The document provides information on how to advise individuals according to their specific allergy history. This document provides guidance regarding four COVID-19 vaccines: Comirnaty® (Pfizer-BioNTech), COVID-19 Vaccine Moderna®, COVID-19 Vaccine Janssen® and Vaxzevria® (formerly COVID-19 Vaccine AstraZeneca®).

Frequently Asked Questions about COVID-19 vaccines for people with pre-existing allergic conditions

Published 12 August 2021